secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001607062-22-000669
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma increases authorized Series A Preferred shares to 739M
----------------------------------------------------------------------

- Series A Preferred Stock authorized shares increased to 739,000,000 via amendment to Certificate of Designation.
- Amendment to Section 1 of the Certificate of Designation effective November 3, 2022.
- Company presented at Emerging Growth Conference on November 9, 2022; video available via YouTube link.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000669/0001607062-22-000669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000669/rgbp111022form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer